FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy

Farmakokinetika gastrointestinalnih lekova od značaja za racionalnu farmakoterapiju

Thumbnail
2004
543.pdf (243.7Kb)
Authors
Pokrajac, Milena
Miljković, Branislava
Article (Published version)
Metadata
Show full item record
Abstract
Although much progress in the pharmacotherapeutic treatment of gastrointestinal diseases has been made during recent years, a lot of research is still needed in order to elucidate exact disease mechanisms, and to develop corresponding drugs. From the treatmens of Helicobacter pylori infections which are still far from ideal, through pharmacotherapy of irritable bowel syndrome which is not satisfactory, to directon for recognition and integration of important factors in pharmacotherapy of inflammatory bowel disease (genetic, infectious, immunologic and inflammatory), there are many open questions. The pharmacotherapy research today goes towards development of new drugs and vaccines based on the discovery of new receptors, appreciation of influence of important general and individual factors of diseases, as well as preventive and pharmacoeconomic treatment considerations. Pharmacokinetic principles considerations are necessary within all the pharmacotherapy ways, in order to develop drug...s and drug products of better pharmacokinetics, and to provide individualized, effective and safe, as well as economic (rational) pharmacotherapy.

Iako je tokom poslednjih godina učinjen veliki progres u farmakoterapiji gastrointestinalnih oboljenja, još uvek je potrebno mnogo istraživanja da bi se razjasnili egzaktni mehanizmi bolesti i razvili odgovarajući lekovi. Od tretmana infekcije sa Helicobacter pylori, koji se još uvek smatraju daleko od idealnih, preko farmakoterapije iritabilnog sindroma creva koja je nezadovoljavajuća, do usmeravanja na uvažavanje faktora značajnih za farmakoterapiju inflamatornog oboljenja creva (genetički, infektivni, imunološki i inflamatorni), još je mnogo otvorenih pitanja. Farmakoterapijska istraživanja danas idu u pravcu razvoja novih lekova i vakcina zasnovanih na otkriću novih receptora, uvažavanju uticaja značajnih opštih i individualnih faktora bolesti, kao i preventivnim i farmakoekonomskim razmatranjima lečenja. Razmatranje farmakokinetičkih principa je potrebno u okviru svih farmakoterapijskih pravaca, u cilju iznalaženja lekova i preparata bolje farmakokinetike i sprovođenja individuali...zovane, efikasne i bezbedne, kao i ekonomične (racionalne) farmakoterapije.

Keywords:
pharmacokinetics / gastrointestinal drugs / rational pharmacotherapy
Source:
Arhiv za farmaciju, 2004, 54, 3, 193-210
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

ISSN: 0004-1963

[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_farfar_545
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/545
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Pokrajac, Milena
AU  - Miljković, Branislava
PY  - 2004
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/545
AB  - Although much progress in the pharmacotherapeutic treatment of gastrointestinal diseases has been made during recent years, a lot of research is still needed in order to elucidate exact disease mechanisms, and to develop corresponding drugs. From the treatmens of Helicobacter pylori infections which are still far from ideal, through pharmacotherapy of irritable bowel syndrome which is not satisfactory, to directon for recognition and integration of important factors in pharmacotherapy of inflammatory bowel disease (genetic, infectious, immunologic and inflammatory), there are many open questions. The pharmacotherapy research today goes towards development of new drugs and vaccines based on the discovery of new receptors, appreciation of influence of important general and individual factors of diseases, as well as preventive and pharmacoeconomic treatment considerations. Pharmacokinetic principles considerations are necessary within all the pharmacotherapy ways, in order to develop drugs and drug products of better pharmacokinetics, and to provide individualized, effective and safe, as well as economic (rational) pharmacotherapy.
AB  - Iako je tokom poslednjih godina učinjen veliki progres u farmakoterapiji gastrointestinalnih oboljenja, još uvek je potrebno mnogo istraživanja da bi se razjasnili egzaktni mehanizmi bolesti i razvili odgovarajući lekovi. Od tretmana infekcije sa Helicobacter pylori, koji se još uvek smatraju daleko od idealnih, preko farmakoterapije iritabilnog sindroma creva koja je nezadovoljavajuća, do usmeravanja na uvažavanje faktora značajnih za farmakoterapiju inflamatornog oboljenja creva (genetički, infektivni, imunološki i inflamatorni), još je mnogo otvorenih pitanja. Farmakoterapijska istraživanja danas idu u pravcu razvoja novih lekova i vakcina zasnovanih na otkriću novih receptora, uvažavanju uticaja značajnih opštih i individualnih faktora bolesti, kao i preventivnim i farmakoekonomskim razmatranjima lečenja. Razmatranje farmakokinetičkih principa je potrebno u okviru svih farmakoterapijskih pravaca, u cilju iznalaženja lekova i preparata bolje farmakokinetike i sprovođenja individualizovane, efikasne i bezbedne, kao i ekonomične (racionalne) farmakoterapije.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy
T1  - Farmakokinetika gastrointestinalnih lekova od značaja za racionalnu farmakoterapiju
VL  - 54
IS  - 3
SP  - 193
EP  - 210
UR  - https://hdl.handle.net/21.15107/rcub_farfar_545
ER  - 
@article{
author = "Pokrajac, Milena and Miljković, Branislava",
year = "2004",
abstract = "Although much progress in the pharmacotherapeutic treatment of gastrointestinal diseases has been made during recent years, a lot of research is still needed in order to elucidate exact disease mechanisms, and to develop corresponding drugs. From the treatmens of Helicobacter pylori infections which are still far from ideal, through pharmacotherapy of irritable bowel syndrome which is not satisfactory, to directon for recognition and integration of important factors in pharmacotherapy of inflammatory bowel disease (genetic, infectious, immunologic and inflammatory), there are many open questions. The pharmacotherapy research today goes towards development of new drugs and vaccines based on the discovery of new receptors, appreciation of influence of important general and individual factors of diseases, as well as preventive and pharmacoeconomic treatment considerations. Pharmacokinetic principles considerations are necessary within all the pharmacotherapy ways, in order to develop drugs and drug products of better pharmacokinetics, and to provide individualized, effective and safe, as well as economic (rational) pharmacotherapy., Iako je tokom poslednjih godina učinjen veliki progres u farmakoterapiji gastrointestinalnih oboljenja, još uvek je potrebno mnogo istraživanja da bi se razjasnili egzaktni mehanizmi bolesti i razvili odgovarajući lekovi. Od tretmana infekcije sa Helicobacter pylori, koji se još uvek smatraju daleko od idealnih, preko farmakoterapije iritabilnog sindroma creva koja je nezadovoljavajuća, do usmeravanja na uvažavanje faktora značajnih za farmakoterapiju inflamatornog oboljenja creva (genetički, infektivni, imunološki i inflamatorni), još je mnogo otvorenih pitanja. Farmakoterapijska istraživanja danas idu u pravcu razvoja novih lekova i vakcina zasnovanih na otkriću novih receptora, uvažavanju uticaja značajnih opštih i individualnih faktora bolesti, kao i preventivnim i farmakoekonomskim razmatranjima lečenja. Razmatranje farmakokinetičkih principa je potrebno u okviru svih farmakoterapijskih pravaca, u cilju iznalaženja lekova i preparata bolje farmakokinetike i sprovođenja individualizovane, efikasne i bezbedne, kao i ekonomične (racionalne) farmakoterapije.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy, Farmakokinetika gastrointestinalnih lekova od značaja za racionalnu farmakoterapiju",
volume = "54",
number = "3",
pages = "193-210",
url = "https://hdl.handle.net/21.15107/rcub_farfar_545"
}
Pokrajac, M.,& Miljković, B.. (2004). The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 54(3), 193-210.
https://hdl.handle.net/21.15107/rcub_farfar_545
Pokrajac M, Miljković B. The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy. in Arhiv za farmaciju. 2004;54(3):193-210.
https://hdl.handle.net/21.15107/rcub_farfar_545 .
Pokrajac, Milena, Miljković, Branislava, "The pharmacokinetics of drugs for gastrointestinal diseases important for the rational pharmacotherapy" in Arhiv za farmaciju, 54, no. 3 (2004):193-210,
https://hdl.handle.net/21.15107/rcub_farfar_545 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB